How Epilepsy Treatment Efficacy Is Determined
Anticonvulsants to Treat Epilepsy and Alternatives
The Classification of Epilepsy and Seizures
Epilepsy Case Presentation and Diagnostic Process
Real-World Practice: Perampanel for Partial-Onset Seizures
A Treatment Option for Uncontrolled Partial-Onset Seizures
How Treatment Efficacy Is Determined
Antiepileptic Therapy Adverse Effects and Nonadherence
Antiepileptic Therapy Half-Life, Dosing & Black Box Warning
Seizure Classification and Goals of Therapy
Epilepsy Prevalence and Therapy Resistance
A 55-Year-Old Woman With Epilepsy
Jacqueline French, MD: Identifying Focal Epilepsy Seizures
The director of Translational Research and Clinical Trials Epilepsy at NYU Grossman School of Medicine discussed the groundwork done with the Human Epilepsy Project for a recent analysis.
Virendra Mishra, PhD: Previous Data on Parkinson Disease Dementia
The Cleveland Clinic researcher discussed the unknowns about Parkinson disease dementia and what has been previously observed in clinical studies.
Raman Malhotra, MD: Highlights From Sleep 2020
The associate professor of neurology at Washington University in St. Louis detailed a number of key presentations on advances and novel medications in the sleep space.
Veronica Hood, PhD: New ICD-10 Codes for Dravet Syndrome
The research coordinator of the Dravet Foundation provided background on the new ICD-10 codes announced for Dravet syndrome and how they came about.
PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published
Neurology News Network for the week ending November 7, 2020.
Pavel Klein, MD: Initiating Conversations on Changing Treatment Strategy
The director of the Mid-Atlantic Epilepsy and Sleep Center in Bethesda, Maryland, described the challenges he’s faced when having to discuss a change in treatment strategies with his patients.
Anup Patel, MD: Telemedicine’s Impact on Lennox-Gastaut Syndrome Care
The section chief of pediatric neurology at Nationwide Children’s Hospital spoke about the effect telemedicine has had on patients with Lennox-Gastaut syndrome throughout the COVID-19 pandemic.
Cannabis and MS: Helping Patients Understand Risks and Benefits Webinar Series
This three-part, educational webinar series provides evidence-based information about the effects of cannabis on MS symptoms, including pain and spasticity.
Raman Malhotra, MD: What to Look Forward to in Sleep Medicine
The associate professor of neurology at Washington University in St. Louis discussed a number of recent advances in therapeutics, as well as diagnostic and measurement devices, in sleep medicine.
James Beck, PhD: The Increased Need for Genetic Testing in Parkinson Disease
The chief scientific officer at the Parkinson’s Foundation discussed PD GENEration, an initiative to provide genetic testing for patients with Parkinson disease.
Jennifer Frontera, MD: Comparing COVID-19 Neurologic Data
The professor of neurology at the NYU Langone Grossman School of Medicine gave her thoughts on how her recently published data on neurologic disorders in COVID-19 compare to previously reported data.
Webinar: Differing Perspectives on Multiple Sclerosis Nursing Care: Patient Program
A 2-part webcast series geared toward MS nursing professionals and patients.
Webinar: Differing Perspectives on Multiple Sclerosis Nursing Care
Joe Verghese, MBBS, MS: Understanding the Pathology of Motoric Cognitive Risk Syndrome
The director of the Montefiore Einstein Center for the Aging Brain discussed the details of his study that will evaluate motoric cognitive risk syndrome.
Raman Malhotra, MD: Increasing the Attention on Insomnia
The associate professor of neurology at Washington University in St. Louis spoke to the need to improve the awareness for insomnia, which remains one of the most common sleep disorders.
Anup Patel, MD: International LGS Awareness Day
The section chief of pediatric neurology at Nationwide Children’s Hospital provided his thoughts on raising awareness for Lennox-Gastaut syndrome on International LGS Day.
Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission
Neurology News Network for the week ending October 31, 2020.
Therapies in Development for Acute Migraine
